The WHO “Global Policy Report on the Prevention and Control of Viral Hepatitis” presents findings from a 2012 survey of member states about their policies and practices around hepatitis. Here are some key findings from the 126 member states that responded to the survey:
• Only 37 percent of the countries have national strategies for viral hepatitis.
• While 82 percent of the countries have established hepatitis surveillance programs, only half include the monitoring of chronic hepatitis B and C, which account for most severe illnesses and deaths, according to WHO.
• Only 50 percent of member states have clinical guidelines for the treatment of hepatitis.
• Fewer than 50 percent of member states include key medications for hepatitis B treatment in their essential medicines list.
• Sixty percent of member states have publicly funded treatment programs.
WHO is developing new hepatitis C guidelines for screening, care and treatment. Some of the report’s recommendations for improving viral hepatitis practices include developing a written national strategy or plan focused on viral hepatitis, conducting regular prevalence surveys, training healthcare providers, establishing national treatment guidelines and including hepatitis medications in essential medicines lists.
More Articles on Hepatitis:
Natividad Medical Center Notifies Nearly 900 Patients of Potential Infection Risk
Neosho Memorial Regional Medical Center Notifies Patients of Infection Risk
HHS Releases Guidelines to Curb Transmission of HIV, HBV, HBC From Transplanted Organs
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.